GIUSEPPA SCALETTA: Open Payments
NPI 1700533494 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 4 payments from 4 companies in 2025. Trend: 2023 $453 · 2024 $363 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $125 |
| GENZYME CORPORATION | 1 | $123 |
| Janssen Biotech, Inc. | 1 | $85 |
| Aimmune Therapeutics, Inc. | 1 | $70 |
Products named: Livdelzi, DUPIXENT, TREMFYA, ZENPEP.
Industry payments across WI — which companies pay providers there.
